Cessation of nucleos(t)ide analogues for patients with chronic hepatitis B in Taiwan: Risky but inevitable

^*此作品的通信作者

研究成果: Editorial

原文	English
頁（從 - 到）	515-516
頁數	2
期刊	Journal of the Chinese Medical Association
卷	83
發行號	6
DOIs	https://doi.org/10.1097/JCMA.0000000000000317
出版狀態	Published - 6月 2020

UN SDG

此研究成果有助於以下永續發展目標

@article{a64e508fae644414a4bf4a20dd7198a4,

title = "Cessation of nucleos(t)ide analogues for patients with chronic hepatitis B in Taiwan: Risky but inevitable",

author = "Lee, {I. Cheng} and Huang, {Yi Hsiang}",

year = "2020",

month = jun,

doi = "10.1097/JCMA.0000000000000317",

language = "English",

volume = "83",

pages = "515--516",

journal = "Journal of the Chinese Medical Association",

issn = "1726-4901",

publisher = "Elsevier Taiwan LLC",

number = "6",

}

TY - JOUR

T1 - Cessation of nucleos(t)ide analogues for patients with chronic hepatitis B in Taiwan

T2 - Risky but inevitable

AU - Lee, I. Cheng

AU - Huang, Yi Hsiang

PY - 2020/6

Y1 - 2020/6

UR - http://www.scopus.com/inward/record.url?scp=85086052560&partnerID=8YFLogxK

U2 - 10.1097/JCMA.0000000000000317

DO - 10.1097/JCMA.0000000000000317

M3 - Editorial

C2 - 32243272

AN - SCOPUS:85086052560

SN - 1726-4901

VL - 83

SP - 515

EP - 516

JO - Journal of the Chinese Medical Association

JF - Journal of the Chinese Medical Association

IS - 6

ER -